|Articles|May 11, 2021

Pharmaceutical Executive

  • Pharmaceutical Executive-05-01-2021
  • Volume 41
  • Issue 5

Pharmaceutical Executive's 2021 Emerging Pharma Leaders

Pharm Exec profiles 13 diverse leaders vital to the future of the biopharma industry.

Click on the links below to read the profiles of Pharm Exec's 2021 Emerging Pharma Leaders.

Karen Akinsanya, Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D, Schrödinger

Sally Allain, Head of Johnson & Johnson Innovation, LLC – JLABS @ Washington, DC

Daniel Getts, CEO, Myeloid Therapeutics

Simba Gill, PhD, CEO, Evelo Biosciences

Michael Henderson, MD, Chief Business Officer, BridgeBio Pharma

Donna Hunt Hodge, Director, New Product Development, Inherited Retinal Diseases, Johnson & Johnson

John Hoekman, PhD, Co-Founder & Chief Scientific Officer, Impel NeuroPharma

Lukasz Jarzyna, Head of Global Value, Access, and Pricing, Alexion Pharmaceuticals

William “BJ” Jones, Chief Commercial Officer, Migraine & Common Disease, Biohaven Pharmaceuticals

Kirsten Kester, Vice President, Business Development, Obsidian Therapeutics

Carsten Linnemann, PhD, CEO, Neogene Therapeutics

Carla Pearson, Vice President and Global Commercial Lead for Cabotegravir, ViiV Healthcare

Teisha Robinson, Director of Strategic Accounts-Emerging Accounts, Johnson & Johnson Health Care Systems Inc.

*From a pool of over 100 nominations, these final selections were judged in a blinded process by three Editorial Advisory Board members and a former EPL.

Articles in this issue

over 4 years ago

A Fortuitous, Rewarding Path

over 4 years ago

The Power of Giving Back

over 4 years ago

Restless for Results

over 4 years ago

On the Fast Track

over 4 years ago

Inspiring Greatness in Others

over 4 years ago

Access and Altruism

over 4 years ago

A Drug Developer at Heart

over 4 years ago

An Eye for Marketing, Mentorship

over 4 years ago

Bullish on Breakthroughs

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.